ANL 28.85 Increased By ▲ 0.50 (1.76%)
ASC 15.15 Increased By ▲ 0.01 (0.07%)
ASL 24.15 Increased By ▲ 0.50 (2.11%)
AVN 97.95 Increased By ▲ 2.35 (2.46%)
BOP 9.30 Increased By ▲ 0.10 (1.09%)
BYCO 10.35 Increased By ▲ 0.28 (2.78%)
DGKC 135.50 Increased By ▲ 3.00 (2.26%)
EPCL 49.98 Increased By ▲ 1.28 (2.63%)
FCCL 25.16 Increased By ▲ 0.61 (2.48%)
FFBL 25.22 Decreased By ▼ -0.41 (-1.6%)
FFL 16.04 Increased By ▲ 0.04 (0.25%)
HASCOL 11.07 Increased By ▲ 0.01 (0.09%)
HUBC 85.00 Increased By ▲ 0.80 (0.95%)
HUMNL 7.70 Increased By ▲ 0.43 (5.91%)
JSCL 25.75 Increased By ▲ 1.10 (4.46%)
KAPCO 37.45 Increased By ▲ 1.35 (3.74%)
KEL 4.17 Increased By ▲ 0.12 (2.96%)
LOTCHEM 15.13 Increased By ▲ 0.37 (2.51%)
MLCF 47.18 Increased By ▲ 1.18 (2.57%)
PAEL 39.40 Increased By ▲ 0.65 (1.68%)
PIBTL 12.04 Decreased By ▼ -0.01 (-0.08%)
POWER 10.65 Increased By ▲ 0.05 (0.47%)
PPL 91.00 Increased By ▲ 0.40 (0.44%)
PRL 26.69 Increased By ▲ 0.39 (1.48%)
PTC 9.05 Decreased By ▼ -0.09 (-0.98%)
SILK 1.45 Increased By ▲ 0.05 (3.57%)
SNGP 38.75 Decreased By ▼ -0.25 (-0.64%)
TRG 145.70 Increased By ▲ 6.95 (5.01%)
UNITY 32.90 Increased By ▲ 0.75 (2.33%)
WTL 1.61 Increased By ▲ 0.05 (3.21%)
BR100 4,959 Increased By ▲ 85.49 (1.75%)
BR30 25,734 Increased By ▲ 497.97 (1.97%)
KSE100 45,966 Increased By ▲ 603.04 (1.33%)
KSE30 19,199 Increased By ▲ 314.87 (1.67%)
Pakistan

COVID-19: China's CanSino to offer Pakistan 20 million doses

  • Company has already applied with Pakistan’s drug regulator (Drug Regulatory Authority of Pakistan) to get approval.
  • There might be a 25% decrease in procurement costs as the company claims it will fill vaccine vials in Pakistan.
Updated 22 Jan 2021

Chinese vaccine maker CanSino Biologics has offered 20 million doses of its COVID-19 vaccine to Pakistan, Bloomberg reported on Friday.

The vaccine maker will be giving Pakistan preferential access and pricing, Bloomberg quoted Hasan Abbas Zaheer, technical adviser at AJM Pharma Pvt.

It has already applied with Pakistan’s drug regulator (Drug Regulatory Authority of Pakistan) to get approval.

The company is also close to releasing the results of its vaccine’s final-stage clinical trials that were being conducted in Pakistan, Russia, Mexico, and Chile.

There might be a 25% decrease in procurement costs as the company claims it will fill vaccine vials in Pakistan.

Zaheer said, “We need to keep in mind that this coronavirus vaccine is a very scarce commodity, highly in demand, and you know the other countries many months ago started the advance booking, we also need to do the same, we are already late on that.”

“Once Pakistan does a booking, we will be in a position to know the delivery. I am sure the delivery will be much before other manufacturers,” he added.

The development comes a day after Pakistan government announced that China would offer Pakistan 500,000 doses of its COVID-19 vaccines by January 31.

CanSino has also agreed to supply 35 million doses to Mexico while Malaysia is in talks to get 3.5 million shots.